Brief: Enlivex Announces Second Quarter 2022 Financial Results And Provides Business Update
22/08/2022 13:12
Aug 22 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES A BUSINESS UPDATE
* ENLIVEX THERAPEUTICS LTD - AS OF JUNE 30, 2022, CO HAD
CASH,
CASH EQUIVALENTS, AND SHORT-TERM DEPOSITS OF $62.5 MILLION
* ENLIVEX THERAPEUTICS LTD - BELIEVES EXISTING CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND OPERATING EXPENSES AND CAPEX
REQUIREMENTS THROUGH Q3 OF 2024
Source text for Eikon: ID:nGNX4T9DTH
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment